Literature DB >> 17626997

A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis.

Joel B Mason1, Aaron Dickstein, Paul F Jacques, Paul Haggarty, Jacob Selhub, Gerard Dallal, Irwin H Rosenberg.   

Abstract

Nationwide fortification of enriched uncooked cereal grains with folic acid began in the United States and Canada in 1996 and 1997, respectively, and became mandatory in 1998. The rationale was to reduce the number of births complicated by neural tube defects. Concurrently, the United States and Canada experienced abrupt reversals of the downward trend in colorectal cancer (CRC) incidence that the two countries had enjoyed in the preceding decade: absolute rates of CRC began to increase in 1996 (United States) and 1998 (Canada), peaked in 1998 (United States) and 2000 (Canada), and have continued to exceed the pre-1996/1997 trends by 4 to 6 additional cases per 100,000 individuals. In each country, the increase in CRC incidence from the prefortification trend falls significantly outside of the downward linear fit based on nonparametric 95% confidence intervals. The statistically significant increase in rates is also evident when the data for each country are analyzed separately for men and women. Changes in the rate of colorectal endoscopic procedures do not seem to account for this increase in CRC incidence. These observations alone do not prove causality but are consistent with the known effects of folate on existing neoplasms, as shown in both preclinical and clinical studies. We therefore hypothesize that the institution of folic acid fortification may have been wholly or partly responsible for the observed increase in CRC rates in the mid-1990s. Further work is needed to definitively establish the nature of this relationship. In the meantime, deliberations about the institution or enhancement of fortification programs should be undertaken with these considerations in mind.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626997     DOI: 10.1158/1055-9965.EPI-07-0329

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  129 in total

Review 1.  Effects and safety of periconceptional folate supplementation for preventing birth defects.

Authors:  Luz Maria De-Regil; Ana C Fernández-Gaxiola; Therese Dowswell; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

Review 2.  Is dietary fat, vitamin D, or folate associated with pancreatic cancer?

Authors:  G V Sanchez; S J Weinstein; R Z Stolzenberg-Solomon
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

3.  Folate intake and risk of colorectal cancer and adenoma: modification by time.

Authors:  Jung Eun Lee; Walter C Willett; Charles S Fuchs; Stephanie A Smith-Warner; Kana Wu; Jing Ma; Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2011-01-26       Impact factor: 7.045

4.  Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.

Authors:  Shabana Shabbeer; Simon A Williams; Brian W Simons; James G Herman; Michael A Carducci
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-02

5.  Prevention and schizophrenia--the role of dietary factors.

Authors:  John McGrath; Alan Brown; David St Clair
Journal:  Schizophr Bull       Date:  2010-10-25       Impact factor: 9.306

6.  High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population.

Authors:  Torukiri I Ibiebele; Maria Celia Hughes; Nirmala Pandeya; Zhen Zhao; Grant Montgomery; Nick Hayward; Adèle C Green; David C Whiteman; Penelope M Webb
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

7.  Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.

Authors:  Holly R Harris; Daniel W Cramer; Allison F Vitonis; Mary DePari; Kathryn L Terry
Journal:  Int J Cancer       Date:  2011-11-08       Impact factor: 7.396

8.  Selenium, folate, and colon cancer.

Authors:  Alexandra Connelly-Frost; Charles Poole; Jessie A Satia; Lawrence L Kupper; Robert C Millikan; Robert S Sandler
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

9.  A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations.

Authors:  Noel Pabalan; Hamdi Jarjanazi; Hilmi Ozcelik
Journal:  Int J Colorectal Dis       Date:  2013-01-16       Impact factor: 2.571

10.  Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Brietta M Oaks; Kevin W Dodd; Cari L Meinhold; Li Jiao; Timothy R Church; Rachael Z Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2009-12-09       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.